Navigation Links
Researchers discover underlying mechanisms of skin hardening syndromes
Date:5/17/2011

(Boston) - Researchers from Boston University School of Medicine (BUSM) have discovered new details about the underlying mechanisms of skin hardening syndromes. The team connected pharmacological properties of the Novartis Pharma AG drug called balicatib to the skin disorder for the first time after investigating adverse reactions suffered by patients participating in a clinical trial for the treatment of osteoporosis. These findings appear online in the Journal of the American Academy of Dermatology.

Balicatib was developed recently as an osteoporosis drug that can inhibit CathepsinK (catK), an enzyme involved with bone degradation. In a recent trial however, several patients on balicatib experienced hardening of the skin, most frequently around the neck, chest and abdomen. After examining the cases and relating them to recent reports of cathepsin K expression in the skin and the role of cathepsin K in degrading collagen and elastin, the investigators determined that the changes were a direct effect of the drug.

This case study adds a new class of medication to the short list of agents that induce skin hardening syndromes. It also proves that catK affects the skin as well as bones, and marks the first time that skin hardening can be convincingly linked to the pharmacologic properties of a drug.

"This observation emphasizes the importance of intracellular collagen degradation in the skin, a pathway so far vastly underappreciated," said Thomas Ruenger, MD, PhD, a professor and vice-chair of dermatology at BUSM. "This observation also sheds new light on our understanding of the mechanisms involved in morphea, or skin hardening. Failed collagen degradation has so far not been thought to cause morphea."

The researchers believe these findings have far-reaching implications for osteoporosis patients and those suffering from skin hardening syndromes.


'/>"/>

Contact: Nathan Bliss
nathan.bliss@bmc.org
617-638-8490
Boston University Medical Center
Source:Eurekalert

Page: 1

Related medicine news :

1. Researchers map all the fragile sites of the yeast Saccharomyces cerevisiaes genome
2. UH Case Medical Center researchers publish promising findings for advanced cervical cancer
3. Researchers discover new way to kill pediatric brain tumors
4. Researchers Who Discovered First Genes for Stuttering will Present Findings to the National Stuttering Association
5. Researchers create drug to keep tumor growth switched off
6. Urine protein test might help diagnose kidney damage from lupus, UT Southwestern researchers find
7. GUMC researchers say flower power may reduce resistance to breast cancer drug tamoxifen
8. Clemson researchers develop hands-free texting application
9. Researchers find biomarkers in saliva for detection of early-stage pancreatic cancer
10. Researchers chart genomic map spanning over 2 dozen cancers
11. Researchers discover second protective role for tumor-suppressor
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/29/2014)... July 29, 2014 Current Back2Basics long-term ... pain medication post foot surgery during his first six months ... foot surgery – twice on one foot, once on the ... “I broke my foot a year ago and was prescribed ... to Jon by a friend from home who’d recently completed ...
(Date:7/29/2014)... Consilium Staffing, Your Partner in Locum Tenens, ... point of 2014, with strong indications the Irving, Texas-based firm ... this year. , “This is a great time to be ... Staffing. , “We are proud of what we have ... are even more excited about how things are shaping up ...
(Date:7/29/2014)... July 29, 2014 In today’s world, a ... to get. Snoring and sleep apnea (a medical problem where ... and their bed partners of the rest they need to ... the population snores and 20 million people in the United ... been diagnosed and treated; and of those treated, many cannot ...
(Date:7/29/2014)... latest blog post at http://www.perwickstrom.com , entrepreneur, author, speaker ... ways to light the “fire” in employees. , “Employers are ... some it’s a losing battle,” commented Per Wickstrom . ... employees get to the next level; which not only helps ... Per Wickstrom, 6 ways to light the “fire” in employees ...
(Date:7/29/2014)... Angeles, CA (PRWEB) July 29, 2014 ... of 3.1 out of 5. This score reflects a ... result of the large number of suppliers, the product's ... tank market, says IBISWorld analyst Jordan Weinstein. IBISWorld estimates ... buyers with a substantial number of supplier options. However, ...
Breaking Medicine News(10 mins):Health News:Back2Basics Sober Living Resident Overcomes Obstacle in Early Sobriety 2Health News:Consilium Staffing Experiences Significant Revenue Growth 2Health News:Snoring: Bad for Relationships, Bad for Health 2Health News:Snoring: Bad for Relationships, Bad for Health 3Health News:Per Wickstrom’s Latest Blog Post Lists 6 Ways to Light the “Fire” in Employees 2Health News:Septic Tanks Procurement Category Market Research Report Now Available from IBISWorld 2Health News:Septic Tanks Procurement Category Market Research Report Now Available from IBISWorld 3Health News:Septic Tanks Procurement Category Market Research Report Now Available from IBISWorld 4
... COLUMBIA, Mo. Nursing is among construction and law ... on-the-job injuries, according to the U.S. Department of Labor. ... many of the injuries. Those injuries often can be ... nursing students at the University of Missouri have a ...
... a hormone disorder that causes a diverse array of ... wasting, and ultimately death. It is caused by a ... the secretion of excess amounts of adrenocorticotropic hormone (ACTH). ... tumors commonly recur, meaning that new treatment options are ...
... (HealthDay News) -- Among older married Americans, an active sex ... with life in general, according to a new study. ... of 238 married people 65 and older who took part ... predicted both overall and marital happiness, and this association remained ...
... use to rate nursing home quality does not provide ... account the degree of cognitive impairment of their patient ... according to a new study. Focusing on statistics ... and the Regenstrief Institute report on the inadequacy of ...
... A patient,s viewpoint of the severity of irritable bowel ... physical symptoms of IBS but broader psychological problems, according ... Hepatology , the official journal of the American Gastroenterological ... in a cost-effective manner within tight time constraints and ...
... 20 (HealthDay News) -- Holiday foods and feasts can ... gastroesophageal reflux disease (GERD), but there are things they ... GERD occurs when a faulty valve between the ... into the esophagus. Symptoms of GERD include heartburn, acid ...
Cached Medicine News:Health News:New safe practices room provides prevention training space for nursing students 2Health News:Regular Sex May Be Key to Happy Marriage for Seniors 2Health News:Nursing home quality scorecards don't tell the whole score 2Health News:Psychological factors affect IBS patients' interpretation of symptom severity 2Health News:Holiday Foods May Trigger GERD Symptoms 2
(Date:7/28/2014)... 2014  Surgical Theater, LLC announced today the ... Advisory Board. New members include Ori J. ... Development and New Technologies for Given Imaging Ltd., ... Vice President and General Manager of Philips Healthcare,s ... simulation technology to brain surgery and has developed ...
(Date:7/28/2014)...  VigeneTech, Inc, in collaboration with BioLegend, Inc., ... Software, an OEM software solution for analysis of ... offers varieties of bead-based multi-analyte immunoassay products for ... VigeneTech,s data analysis software, FCS data files can ... LEGENDplex™ software is a robust ...
(Date:7/28/2014)... , July 28, 2014  Array BioPharma Inc. ... for the fourth quarter and full year ... call to discuss those results on Tuesday, ... Officer and Michael Carruthers , Chief ... InformationDate:Tuesday, August 12, 2014Time:9:00 a.m. Eastern TimeToll-Free:(800) ...
Breaking Medicine Technology:Surgical Theater Names Former Given Imaging Ltd. and Philips Healthcare Executives to Business Advisory Board 2Surgical Theater Names Former Given Imaging Ltd. and Philips Healthcare Executives to Business Advisory Board 3Surgical Theater Names Former Given Imaging Ltd. and Philips Healthcare Executives to Business Advisory Board 4Surgical Theater Names Former Given Imaging Ltd. and Philips Healthcare Executives to Business Advisory Board 5VigeneTech Releases New Powerful Software for Flow Cytometry Data Analysis 2
... THOUSAND OAKS, Calif., Nov. 5, 2011 Amgen ... the first three years of the open-label extension study of ... of Prolia® (denosumab) treatment in postmenopausal women with osteoporosis was ... consistent reduction in markers of bone turnover. These results will ...
... Tibotec Pharmaceuticals (Tibotec), one of the Janssen (Janssen) ... analysis of PILLAR, a phase 2b study of the ... in treatment-naive patients with chronic genotype 1 HCV, as ... Annual Meeting of the American Association for the Study ...
Cached Medicine Technology:Prolia® (denosumab) Open-Label Extension Trial Showed Continued Increase in Bone Mineral Density Over Six Years With Similar Safety Profile Observed in Original Fracture Trial 2Prolia® (denosumab) Open-Label Extension Trial Showed Continued Increase in Bone Mineral Density Over Six Years With Similar Safety Profile Observed in Original Fracture Trial 3Prolia® (denosumab) Open-Label Extension Trial Showed Continued Increase in Bone Mineral Density Over Six Years With Similar Safety Profile Observed in Original Fracture Trial 4Prolia® (denosumab) Open-Label Extension Trial Showed Continued Increase in Bone Mineral Density Over Six Years With Similar Safety Profile Observed in Original Fracture Trial 5Prolia® (denosumab) Open-Label Extension Trial Showed Continued Increase in Bone Mineral Density Over Six Years With Similar Safety Profile Observed in Original Fracture Trial 6Prolia® (denosumab) Open-Label Extension Trial Showed Continued Increase in Bone Mineral Density Over Six Years With Similar Safety Profile Observed in Original Fracture Trial 7Prolia® (denosumab) Open-Label Extension Trial Showed Continued Increase in Bone Mineral Density Over Six Years With Similar Safety Profile Observed in Original Fracture Trial 8Prolia® (denosumab) Open-Label Extension Trial Showed Continued Increase in Bone Mineral Density Over Six Years With Similar Safety Profile Observed in Original Fracture Trial 9Tibotec to Present Final Safety and Efficacy Results From Phase 2b PILLAR Study of Once-Daily TMC435 in Late-Breaker at AASLD 2Tibotec to Present Final Safety and Efficacy Results From Phase 2b PILLAR Study of Once-Daily TMC435 in Late-Breaker at AASLD 3Tibotec to Present Final Safety and Efficacy Results From Phase 2b PILLAR Study of Once-Daily TMC435 in Late-Breaker at AASLD 4
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
Medicine Products: